Significant frequency deviation of the class I polymorphism HLA-A10 in schizophrenic patients [5]

Journal of Medical Genetics

Volumn 40, Issue 3, 2003, Pages 217-219

  Laumbacher, B ^a   Muller N ^a   Bondy, B ^a   Schlesinger, B ^a   Gu, S ^a   Fellerhoff, B ^a   Wank, R ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA C ANTIGEN;

ANTIGEN EXPRESSION; CHROMOSOME 6P; CONTROLLED STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HLA TYPING; HUMAN; HUMAN CELL; LETTER; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; SCHIZOPHRENIA;

GENE FREQUENCY; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; STATISTICS;

EID: 0037338316     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (26)

1. Besedovsky HO, Sorkin E. Network of immune-neuroendocrine interaction. Clin Exp Immunol 1977;27:1-12.
2. Blalock JE. The immune system our sixth sense. The Immunologist 1994;2:8-15.
3. Besser M, Wank R. Clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNS by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol 1998;162:6303-6.
4. Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L. Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates integrin function. Eur J Immunol 2001;31:3504-12.
5. Kety SS, Rosenthal D, Wender PH, Schulsinger F. Mental illness in the biological and adoptive families of adopted schizophrenics. Am J Psychiatry 1971;128:302-6.
6. Barondes SH, Alberts BM. Andreasen NC, Bargmann C, Benes F, Goldman-Rakic P, Gottesman I, Heinemann SF, Jones EG, Kirschner M, Lewis D, Raff M, Roses A, Rubenstein J, Snyder S, Watson SJ, Weinberger DR, Yolken RH. Workshop on schizophrenia. Proc Natl Acad Sci USA 1997;94:1612-14.
7. Moldin SO, Gottesmann II. At issue-genes, experience, and chance in schizophrenia-positioning for the 21st century. Schizophr Bull 1997;23:547-61.
8. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, Shimkwin R, Webb BT, Zhang J, Walsh D. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet 1995;11:287-93.
9. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, Arolt V, Blackwood D, Liu X, Sjogren B. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995;11:321-4.
10. Schwab SG, Albus M, Hallmayer J, Honig S, Borrmann M, Lichtermann D, Ebstein PR, Ackenheil M, Lerer B, Risch N. Evaluation of susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 1995;11:325-7.
11. Antonarakis SE, Blouin JL, Pulver AE, Wolyniec P, Lasseter VK, Nestadt G, Kasch L, Babb R, Kazazian HH, Dombroski B. Schizophrenia susceptibility and chromosome 6p24-p22. Nat Genet 1995;11:235-6.
12. Schlesinger BC, Laumbacher B, Wank R. Sequence based typing (SBT) of HLA-C alleles in 214 Caucasians using the automatic DNA sequencer ALF. In: Charron D, ed. Proceedings of the Twelfth International Histocompatibility Workshop and Conference. Vol. II. Paris: EDK, 1997:380-2.
13. Grosskopf A, Müller N, Malo A, Wank R. Potential role for the narcolepsy and multiple sclerosis associated HLA allele in schizophrenia subtypes. Schiz Res 1998;30:187-9.
14. Wimmer A, Graf A, Wank R. Automated measurement of cell destruction. Infusionstherapie 1992;19:130-3.
15. Ivanyi P, Ivanyi D, Zemek P. HLA-Cw4 in paranoid schizophrenia. Tissue Antigens 1977;9:41-4.
16. Bechter K, Herzog S, Estler HC, Schüttler R. Increased psychiatric comorbidity in Borna disease virus seropositive psychiatric patients. Acta Psychiatr Belg 1998;98:190-201.
17. Sequiera JR, Jenning LC, Carrasco LH, Lord MA, Sutton RNP. Detection of herpes-simplex genome in brain tissue. Lancet 1979;ii:609-12.
18. Karlssan H, Bachmann S, Schröder J, McArthur J, Fuller EF, Yolken RH. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia, Proc Natl Acad Sci USA 2001;98:4634-9.
19. Torrey EF, Peterson MR, Brannon WL, Corputer WT, Post RM, van Kammen DP. Immunoglobulins and viral antibodies in psychiatric patients. Br J Psychiatry 1978;132:342-8.
20. Albrecht P, Boone E, Daniel N, Torrey EF, Hicks JT. Raised cytomegalus-antibody level in cerebrospinal fluid of schizophrenic patients. Lancet 1980;ii:769-72.
21. Fan W, Cai W, Parimoo S, Lennon GG, Weissman SM. Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics 1996;44:97-103.
22. Wedekind C, Seebeck T, Bettens F, Paepke AJ. MHC-dependent mate preferences in humans. Proc R Sac Land B Biol Sci 1995;260:245-9.
23. Solheim JC, Carreno BM, Hansen TH. Are transporters associated with antigen processing (TAP) and tapasin class I MHC chaperones? J Immunol 1997;158:541.
24. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994;79:13.
25. McGrath JJ, Welham JL. Season of birth and schizophrenia: a systematic review and meta-analysis of data from the southern hemisphere. Schiz Res 1999;35:237-42.
26. Wank R. Psychiatric diseases require longterm adoptive immunotherapy. Med Hypotheses 2002;59:154-8.